Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Christian Lund

Showing results (11-20 of 70) with videos related to

Pageof 7
Sort By:
Pharmacoepidemiology and Drug Safety|August 10, 2023
A case for screening real-world data for collateral drug benefits: Glucagon-like peptide 1 receptor agonists and bile acid diarrheaMartin Torp Rahbek, Lars Christian Lund, Jesper Hallas
Ugeskrift for Laeger|April 26, 2018
[Treatment of vancomycin-resistant enterococcal infections]Lars Christian Lund, Barbara Juliane Holzknecht, Ulrik Stenz Justesen
Acta Psychiatrica Scandinavica|June 17, 2024
Post-pandemic trends in psychotropic medication use in Danish children, adolescents, and young adultsHelene Kildegaard, Rikke Wesselhoeft, Lars Christian Lund, et al.
The Lancet. Child & Adolescent Health|October 28, 2023
Effectiveness of the quadrivalent live attenuated influenza vaccine against influenza-related hospitalisations and morbidity among children aged 2 to 6 years in Denmark: a nationwide cohort study emulating a target trialHelene Kildegaard, Lars Christian Lund, Anton Pottegård, et al.
Drug Safety|January 27, 2025
Sequential Epidemiological Analyses of Real-World Data: A Tool for Prospective Drug Safety Surveillance from the Rofecoxib ExampleSaad Hanif Abbasi, Lars Christian Lund, Jesper Hallas, et al.
Ugeskrift for Laeger|March 6, 2024
Lars Christian Lund, Anton Pottegård, Henrik Toft Sørensen, et al.
Ugeskrift for Laeger|March 6, 2024
Lars Christian Lund, Anton Pottegård, Henrik Toft Sørensen, et al.
Journal of Clinical Epidemiology|February 22, 2023
Cox regression using a calendar time scale was unbiased in simulations of COVID-19 vaccine effectiveness & safetyLars Christian Lund, Henrik Støvring, Anton Pottegård, et al.
British Journal of Clinical Pharmacology|March 12, 2024
Screening of dermatology drugs for aberrant use-patterns: An application of epidemiologic estimates and measures of inequality in drug useThomas Delvin, Anette Bygum, Lars Christian Lund, et al.
BMJ (Clinical Research Ed.)|April 12, 2022
Risk of adverse events after covid-19 in Danish children and adolescents and effectiveness of BNT162b2 in adolescents: cohort studyHelene Kildegaard, Lars Christian Lund, Mikkel Højlund, et al.
Pageof 7

Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
Pharmacoepidemiology and Drug Safety|August 10, 2023
A case for screening real-world data for collateral drug benefits: Glucagon-like peptide 1 receptor agonists and bile acid diarrheaMartin Torp Rahbek, Lars Christian Lund, Jesper Hallas
Ugeskrift for Laeger|April 26, 2018
[Treatment of vancomycin-resistant enterococcal infections]Lars Christian Lund, Barbara Juliane Holzknecht, Ulrik Stenz Justesen
Acta Psychiatrica Scandinavica|June 17, 2024
Post-pandemic trends in psychotropic medication use in Danish children, adolescents, and young adultsHelene Kildegaard, Rikke Wesselhoeft, Lars Christian Lund, et al.
The Lancet. Child & Adolescent Health|October 28, 2023
Effectiveness of the quadrivalent live attenuated influenza vaccine against influenza-related hospitalisations and morbidity among children aged 2 to 6 years in Denmark: a nationwide cohort study emulating a target trialHelene Kildegaard, Lars Christian Lund, Anton Pottegård, et al.
Drug Safety|January 27, 2025
Sequential Epidemiological Analyses of Real-World Data: A Tool for Prospective Drug Safety Surveillance from the Rofecoxib ExampleSaad Hanif Abbasi, Lars Christian Lund, Jesper Hallas, et al.
Ugeskrift for Laeger|March 6, 2024
Lars Christian Lund, Anton Pottegård, Henrik Toft Sørensen, et al.
Ugeskrift for Laeger|March 6, 2024
Lars Christian Lund, Anton Pottegård, Henrik Toft Sørensen, et al.
Journal of Clinical Epidemiology|February 22, 2023
Cox regression using a calendar time scale was unbiased in simulations of COVID-19 vaccine effectiveness & safetyLars Christian Lund, Henrik Støvring, Anton Pottegård, et al.
British Journal of Clinical Pharmacology|March 12, 2024
Screening of dermatology drugs for aberrant use-patterns: An application of epidemiologic estimates and measures of inequality in drug useThomas Delvin, Anette Bygum, Lars Christian Lund, et al.
BMJ (Clinical Research Ed.)|April 12, 2022
Risk of adverse events after covid-19 in Danish children and adolescents and effectiveness of BNT162b2 in adolescents: cohort studyHelene Kildegaard, Lars Christian Lund, Mikkel Højlund, et al.
Pageof 7